期刊文献+

多发性骨髓瘤肾损害的血液净化治疗 被引量:1

Blood Purification Therapy for Renal Damage of Multiple Myeloma
原文传递
导出
摘要 骨髓瘤肾病是多发性骨髓瘤(MM)最常见和严重的并发症。治疗该病的关键是降低血浆轻链蛋白浓度,改善半数以上骨髓瘤肾衰患者的肾功能,从而改善MM患者的预后。目前随着对MM认识的进展,骨髓瘤肾病的合理治疗引起重视和讨论。该文主要从血液净化治疗骨髓瘤肾病的必要性、有效性、临床治疗经验、选用合理治疗方案以及治疗前景等方面进行综述。 The myeloma kidney disease is the common and severe complication of multiple myeloma (MM).The key to treatment is reducing the concentration of light chain protein in the serum,improving the kidney function of patients with MM,so as to improve prognosis of patients.At present,reasonable treatment for myeloma kidney disease attracts more attention and discussion with the progress of cognition to MM.In this paper,a review is performed from aspects of the necessity and efficacy of blood purification therapy for myeloma kidney disease,clinical treatment experience,how to choose the therapeutic scheme,therapeutic prospect and so on.
机构地区 天津市天和医院
出处 《职业与健康》 CAS 2010年第18期2134-2135,共2页 Occupation and Health
关键词 骨髓瘤肾病 肾衰竭 血液净化 Myeloma kidney disease Renal failure Blood purification
  • 相关文献

参考文献13

  • 1Viertel A, Weidmann E, Ditting T, et al. Management of renal complica- tions inpatientswith advanced multiple myeloma [ J ]. Leuk Lymphoma, 2000,38:513. 被引量:1
  • 2Greipp PR, San M J, Dude BG, et al. International staging sys tern formultiple myeloma[ J]. J Clin Oncol,2005,23:3412- 3420. 被引量:1
  • 3Rentzos M, Anyfanti C, Kaponi A, et al. Chronic inflammatory demyelinating poly-neuropathy: A6-year retrospective clinical study ofah spitalbased population[ J]. J Clin Neurosci ,2007,1:229. 被引量:1
  • 4Modarressi A, Kuriyan M, Harvey G, et al. Heat insoluble cryo globulin associated with gangrene in multiple myeloma[ J]. J Clin Apher,2003, 18:190 - 193. 被引量:1
  • 5Clark WF, Stewart AK, Rock GA, et al. Plasma exchangewhen myeloma presentsasacute renalfailure: a randomized, controlled trial[ J ]. Ann Inten Med,2005,143:777 - 784. 被引量:1
  • 6Arslan O, Ann M, Tek I, et al. Therapeutic plasma exchange in a single center: Ibni Sina experience [ J]. Transfus Apher Sci, 2004, 30: 181 - 184. 被引量:1
  • 7Tricot G, Alberts DS, Johnson C, et al. Safety of autotransplants with high dose melphalan in renalfailure, a pharmacokinetic and toxicity study [ J ]. Clin Cancer Res, 1996,2:947. 被引量:1
  • 8Goddard IR, Stewart WK, Hodson BA, et al. Plasma exchange as a treatment for endogenous glycosaminogly can anticoagulant induced haemorrhage in a patient with myeloma kidney [ J ]. Nephron, 1990,56 : 94 - 96. 被引量:1
  • 9Barosi G, Boceadoro M, Cavo M, et al. Management of yeloma and relat- ed-disorders : guidelines from the Italian Society of Hematology (SIE) , Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO) [ J ]. Haematologica, 2004, 89:717 - 741. 被引量:1
  • 10Clark WF, Stewart AK, Rock GA, et al. Plasmaexchange when myeloma presents asacuterenal failure: aran domized, controlled trial[ J ]. Ann Intern Med,2005 ,143 :777 - 784. 被引量:1

共引文献1

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部